Todd Bazemore, SEE REMARKS at KALA BIO, Inc. (KALA), sold 4,653 shares at $4.75 ($22K) on 2024-06-26, disclosed to the SEC on 2024-06-27.
Scheduled sale ($22k) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KALA | SELL | 2025-06-04 | $13K | — | Filing → |
| KALA | SELL | 2025-01-07 | $15K | — | Filing → |
| KALA | SELL | 2024-06-03 | $13K | — | Filing → |